ER+ BREAST CANCER
Clinical trials for ER+ BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new ER+ BREAST CANCER trials appear
Sign up with your email to follow new studies for ER+ BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New oral drug trial offers hope for Tough-to-Treat cancers
Disease control OngoingThis early-stage trial is testing a new oral medication called BBI-355, both alone and in combination with other drugs, for people with advanced solid tumors that have stopped responding to standard treatments. The study aims to find safe doses and see if the treatment can shrink…
Matched conditions: ER+ BREAST CANCER
Phase: PHASE1 • Sponsor: Boundless Bio, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Radioactive drug trial offers new hope for Tough-to-Treat breast cancer
Disease control OngoingThis early-stage trial is testing an experimental radioactive drug called RYZ101 for people with advanced ER+ breast cancer that has spread and stopped responding to standard treatments. The study aims to find a safe dose and see if the drug can shrink tumors in patients whose ca…
Matched conditions: ER+ BREAST CANCER
Phase: PHASE1, PHASE2 • Sponsor: RayzeBio, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New cancer combo enters safety testing for dozens of tumor types
Disease control OngoingThis early-stage trial is testing the safety and finding the right dose of a two-drug combination (naptumomab estafenatox and durvalumab) for people with advanced or metastatic solid tumors. It will enroll about 120 adults with one of many eligible cancer types, including breast,…
Matched conditions: ER+ BREAST CANCER
Phase: PHASE1 • Sponsor: NeoTX Therapeutics Ltd. • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC